IISPV

What IISPV does

IISPV (Institut d'Investigació Sanitària Pere Virgili) is a non-profit biomedical research foundation registered in the Register of Foundations of the Generalitat de Catalunya, founded in 2005 and headquartered in Tarragona, Spain, with operational sites in Reus, Tarragona, and Tortosa. The institute coordinates health research across the Camp de Tarragona and Terres de l'Ebre regions, acting as the structural research platform for four partner hospitals — Hospital Universitari Sant Joan de Reus, Parc Sanitari Joan XXIII, Hospital de Tortosa Verge de la Cinta, and Institut Pere Mata — together with the Universitat Rovira i Virgili. As of its 20th anniversary in 2025, IISPV reports more than 600 professionals and 38 research groups organized around four research areas: Metabolic Diseases and Nutrition, Oncology, Mental Health and Neurosciences, and Infection, Immunity and Environment.

The institute's core product surface consists of 11 scientific support platforms (including bioinformatics, biostatistics, genomics, proteomics, and biobank services), a Southern Catalonia Clinical Research Unit (UIC) running clinical trials, an International Projects Unit (UPI), an Innovation and Technology Transfer Unit, a CEIm ethics committee, and a structured training plan. Notable outputs include the DIBIOMEC three-biomarker algorithm for prostate cancer prognosis (reported 14% more accurate than PSA), the DIAMET research group's metabolic disease program feeding the spin-off SucciPro S.L., and the CESPED €1.7 million multi-center study on genetic biomarkers of neurodevelopmental disorders. Certifications include HR Excellence in Research (HRS4R) from the European Commission and GDPR compliance.

IISPV's revenue model is government-grant and philanthropy-based. Income streams comprise competitive public research funding from Instituto de Salud Carlos III (ISCIII), EU programs including Horizon Europe and the Recovery and Resilience Facility, institutional funding from the Generalitat de Catalunya, and voluntary donations from individuals and organizations. There is no commercial product pricing; the institute does not sell products or services to customers in the conventional sense, and revenue figures are not publicly disclosed. The go-to-market is institution-to-institution via hospital and university partnerships, with marketing conducted primarily through the website (iispv.cat), social channels, scientific seminars, and PhD Days.

Name

IISPV

Legal name

INSTITUT D'INVESTIGACIÓ SANITÀRIA PERE VIRGILI

Website

https://iispv.cat

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

IISPV is a non-profit biomedical research foundation in Tarragona, Spain, founded in 2005, that coordinates health research across four regional hospitals and the Universitat Rovira i Virgili through 38 research groups and 11 scientific support platforms.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Biomedical research
• Clinical trials
• Scientific platforms
• Health research
• Technology transfer

Headquarters

HQ city

Reus

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Research Project Funding: Public funding from governmental bodies including Instituto de Salud Carlos III (ISCIII), European Union Next Generation funds, and Generalitat de Catalunya for conducting biomedical research projects
2. International Research Grants: Funding from European research programs including Horizon Europe and international collaborative projects
3. Donations and Charitable Contributions: Voluntary donations from individuals and organizations supporting specific research lines, with tax advantages for donors

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

IISPV is a non-profit biomedical research foundation that coordinates and conducts health research in the province of Tarragona, Spain. It operates as a research platform comprising 11 scientific support platforms, 31 research groups across four areas (metabolic diseases, oncology, mental health/neurosciences, infection/immunity), a clinical research unit, an international projects office, a biobank, and an innovation and technology transfer unit. It also delivers training programs for researchers and supports commercialization of research through spin-off companies such as SucciPro S.L.

Product overview

IISPV (Institut d'Investigació Sanitària Pere Virgili) is a non-profit biomedical research foundation established in 2005 that manages health research in the province of Tarragona, Spain. The institute operates as a platform organization comprising 11 scientific support platforms, 31+ research groups, and multiple specialized units. Its core offerings include research programs across four strategic areas: Metabolic Diseases and Nutrition, Oncology, Mental Health and Neurosciences, and Infection, Immunity and Environment. The institute provides commercialization services through its Innovation and Technology Transfer Unit, which has produced spin-off companies like SucciPro S.L. IISPV also delivers clinical research services via its Southern Catalonia Clinical Research Unit, international project support through its UPI office, biobank services, and comprehensive researcher training programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Support Platforms

Quantifiable outcome

• 100 active research projects across 4 research areas and 31 research groups
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Universitat Rovira i Virgili (URV)coreStrategic or Co-development Partner · 1 January 2005Academic founding partner; joint PhD programs, research collaborations, and co-organization of scientific sessions
• ISGlobal (Barcelona Institute for Global Health)coreStrategic or Co-development PartnerCollaborative research partner; joint studies on nutrition, cognitive development and health published in scientific journals like Nutrients and Frontiers in Psychology
• CIBERSAM (Centro de Investigación en Red de Salud Mental)coreStrategic or Co-development PartnerNational mental health research network; 12 groups participated in CESPED project on neurodevelopmental disorders genetics
• AIISEMminorOthersMember of AIISEM innovation network
• BIOCATminorOthersMember of BIOCAT biomedical research and innovation ecosystem in Catalonia
• EIT HealthminorOthersMember of EIT Health European innovation community
• ITEMASminorOthersMember of ITEMAS medical technology platform
• Xarxa TECSAMminorOthersMember of technology network for mental health research
• i4KIDSminorOthersMember of pediatric innovation network

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• IMIM (Hospital del Mar Medical Research Institute): Hospital del Mar-affiliated biomedical research institute in Barcelona focusing on translational and clinical epidemiology research. Closely matches IISPV's mix of clinical research, epidemiology, and public-grant funding.
• IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): Hospital Clínic Barcelona-affiliated biomedical research institute in Catalonia with similar structure: research groups, scientific platforms, clinical trials, and public-grant funding model. Closest direct peer to IISPV in scope and operating model.
• IDIBELL (Institut d'Investigació Biomèdica de Bellvitge): Bellvitge University Hospital-affiliated biomedical research institute in Catalonia with a multi-area research portfolio, scientific platforms, and clinical trial unit. Directly comparable in mandate, scale, and structure.
• IRB Barcelona (Institute for Research in Biomedicine): Barcelona-based biomedical research center with research programs in oncology, metabolism, and chemical biology. Comparable research model with public funding and competitive grant capture, though more focused on basic vs. clinical research than IISPV.
• Vall d'Hebron Institut de Recerca (VHIR): Catalan hospital-based biomedical research institute (Vall d'Hebron University Hospital) running translational research programs, clinical trials, and spin-offs. Comparable to IISPV as a non-profit hospital-affiliated health research foundation.

Emerging players

• CRG (Centre for Genomic Regulation): Barcelona-based international research center with focus on genomics, bioinformatics, and systems biology. Overlaps with IISPV's bioinformatics and genomics support platforms and biomarker work, but is more basic-research oriented.

Regional players

• INCLIVA (Instituto de Investigación Sanitaria): Valencia-based biomedical research institute accredited by ISCIII, running research groups, clinical trials, and training programs. Same Spanish health research institute model but operating in a different regional catchment than IISPV.
• IBIMA (Instituto de Investigación Biomédica de Málaga): Andalusian biomedical research institute with hospital and university partnerships, ISCIII accreditation, and multi-area research programs. Comparable structure to IISPV but serving southern Spain rather than Catalonia.
• IIS La Fe (Instituto de Investigación Sanitaria La Fe): La Fe University Hospital-affiliated research institute in Valencia, ISCIII-accredited, with clinical trials, spin-offs, and research platforms. Directly comparable operating model to IISPV but in a different Spanish region.

Others

• CIBER (Consorcio Centro de Investigación Biomédica en Red): ISCIII-managed national consortium of thematic biomedical research networks across Spain (including CIBERSAM, in which IISPV participates). Not a direct competitor; rather an ecosystem partner that channels funding and collaboration opportunities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/IISPereVirgili
• YouTubeyoutube.com/channel/UCtL1uJmWUmiTf2wmUoRhoYQ
• LinkedInlinkedin.com/school/institut-d%E2%80%99investigaci%C3%B3-sanit%C3%A0ria-pere-virgili-iispv
• Instagraminstagram.com/iispv_

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IISPV